Aquestive Therapeutics, Inc. · NASDAQ:AQST

Davis Matthew W. sold 7,197 Aquestive Therapeutics, Inc. shares (Form 4)

Traded Nov 12, 2026 · Filed Nov 16, 2026

On Nov 12, 2026, Davis Matthew W. (Chief Development Officer) sold 7,197 Aquestive Therapeutics, Inc. shares at US$3.55 for US$25,526 under a trading plan, leaving 87,500 shares. Filed Nov 16, 2026 (Form 4).

Sold
7,197 shares
Price
US$3.55
Value
US$25,526
Holding after
87,500 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Development Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 12, 2026Common StockSale7,197US$3.5587,500Direct

Source

Download original · View original at SEC

Related